Accor: UBS still on hold, maintains target price
(CercleFinance.com) - The group has raised its EBITDA target for FY 2022, which is now expected to be 610 to 640 million euros.
Note that the group was previously targeting EBITDA of over 550 million euros.
Following this announcement, UBS confirms its neutral rating on the stock with target price of 25 euros.
However, the analyst believes that these improved targets could well be a positive catalyst for the shares.
Copyright (c) 2022 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
Note that the group was previously targeting EBITDA of over 550 million euros.
Following this announcement, UBS confirms its neutral rating on the stock with target price of 25 euros.
However, the analyst believes that these improved targets could well be a positive catalyst for the shares.
Copyright (c) 2022 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.